Study Details
This study is designed to evaluate the safety and preliminary effectiveness of one coating concentration of Prefix compared to iliac crest bone in approximately 22 skeletally mature subjects diagnosed with degenerative disc disease (DDD) at one vertebral level (L2-S1).
Primary Sponsor:
Biosurface Engineering Technologies, Inc. (BioSET)
Prinicipal Investigator:
Joseph O'Brien MD
BioSET Prefix Study
cmpaul@mfa.gwu.edu